[go: up one dir, main page]

AU2003290563A1 - Leptin-related peptides - Google Patents

Leptin-related peptides

Info

Publication number
AU2003290563A1
AU2003290563A1 AU2003290563A AU2003290563A AU2003290563A1 AU 2003290563 A1 AU2003290563 A1 AU 2003290563A1 AU 2003290563 A AU2003290563 A AU 2003290563A AU 2003290563 A AU2003290563 A AU 2003290563A AU 2003290563 A1 AU2003290563 A1 AU 2003290563A1
Authority
AU
Australia
Prior art keywords
leptin
related peptides
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003290563A
Other versions
AU2003290563A8 (en
Inventor
Patricia Grasso
Daniel W. Lee
Matthew C. Leinung
Maria Rozhavskaya-Arena
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLF Medical Technology Acceleration Program Inc
Original Assignee
CLF Medical Technology Acceleration Program Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CLF Medical Technology Acceleration Program Inc filed Critical CLF Medical Technology Acceleration Program Inc
Publication of AU2003290563A8 publication Critical patent/AU2003290563A8/en
Publication of AU2003290563A1 publication Critical patent/AU2003290563A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003290563A 2002-10-31 2003-10-31 Leptin-related peptides Abandoned AU2003290563A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42272302P 2002-10-31 2002-10-31
US60/422,723 2002-10-31
PCT/US2003/034820 WO2004039832A2 (en) 2002-10-31 2003-10-31 Leptin-related peptides

Publications (2)

Publication Number Publication Date
AU2003290563A8 AU2003290563A8 (en) 2004-05-25
AU2003290563A1 true AU2003290563A1 (en) 2004-05-25

Family

ID=32230382

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003290563A Abandoned AU2003290563A1 (en) 2002-10-31 2003-10-31 Leptin-related peptides

Country Status (2)

Country Link
AU (1) AU2003290563A1 (en)
WO (1) WO2004039832A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2422806A3 (en) 2004-02-11 2012-06-13 Amylin Pharmaceuticals Inc. Hybrid polypeptides with selectable properties
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
CA2597649A1 (en) 2005-02-11 2006-08-17 Amylin Pharmaceuticals, Inc. Gip analog and hybrid polypeptides with selectable properties
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
AU2006279680B2 (en) 2005-08-11 2012-12-06 Amylin Pharmaceuticals, Llc Hybrid polypeptides with selectable properties
EP2330125A3 (en) 2005-08-11 2012-12-12 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties
GB2451858A (en) * 2007-08-15 2009-02-18 Sergiy Konovchuk Methods of reducing body fat and treating obesity
EP2252314B1 (en) * 2008-02-27 2014-04-09 Temple University - Of The Commonwealth System of Higher Education Leptin agonist and methods of use
EP2416797A4 (en) 2009-04-10 2013-04-24 Amylin Pharmaceuticals Llc AMYLINE AGONIST COMPOUNDS FOR MAMMALS WITH STROGEN DEFICIENCY
US8980843B2 (en) 2009-07-01 2015-03-17 Temple University—Of the Commonwealth System of Higher Education Leptin agonist and methods of use
JP6174489B2 (en) 2010-09-28 2017-08-02 アエゲリオン ファーマシューティカルズ，インコーポレイテッド Highly soluble leptin
DK2729160T3 (en) 2011-07-08 2019-07-01 Aegerion Pharmaceuticals Inc MANIPULATED POLYPEPTIDES WHICH HAVE IMPROVED EFFECT TIME AND REDUCED IMMUNOGENICITY
HUE040496T2 (en) 2012-09-27 2019-03-28 Childrens Medical Ct Corp Compounds for the treatment of obesity and their application procedures
JP6672157B2 (en) 2013-11-26 2020-03-25 ザ チルドレンズ メディカル センター コーポレーション Compounds for treating obesity and methods of using the same
WO2015153933A1 (en) 2014-04-03 2015-10-08 The Children's Medical Center Corporation Hsp90 inhibitors for the treatment of obesity and methods of use thereof
HRP20231076T1 (en) 2016-09-12 2023-12-22 Amryt Pharmaceuticals Inc. Methods of detecting anti-leptin neutralizing antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1598365A1 (en) * 1999-05-17 2005-11-23 ConjuChem Inc. Protection of endogenous therapeutic peptides
ES2309167T3 (en) * 2001-02-19 2008-12-16 Merck Patent Gmbh METHOD FOR IDENTIFYING T-CELL EPITOTS AND METHOD FOR PREPARING MOLECULES WITH REDUCED IMMUNOGENICITY.

Also Published As

Publication number Publication date
WO2004039832A3 (en) 2006-10-05
WO2004039832A2 (en) 2004-05-13
AU2003290563A8 (en) 2004-05-25

Similar Documents

Publication Publication Date Title
AU2003290563A1 (en) Leptin-related peptides
AU2003228863A1 (en) Immunogenic peptides
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2003246644A1 (en) Secreted peptides
AU2003202694A1 (en) Torero protein
AU2003220217A1 (en) Identifying peptide modifications
AU2003302330A1 (en) Antimicrobial peptides
AU2002318053A1 (en) Suplier
AU2002368348A1 (en) Electrosomatogram
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
AU2002348964A1 (en) Snowbike
AU2003300785A1 (en) Carbohydrate-associated proteins
GB0219980D0 (en) Peptides
AU2002344387A1 (en) Multifunction-pillow
AU2003211501A1 (en) Peptides
AU2003236908A1 (en) Proteins
AU2003295760A1 (en) Organelle-associated proteins
AU2003254865A1 (en) Akt2-BINDING PROTEIN
AUPS130102A0 (en) Novel peptides
AU2003211532A1 (en) Novel polypeptide
AU2002328853A1 (en) Carcinoma-related peptides
AU2002100508A4 (en) Photocard
AU2002100498A4 (en) Linline
AU2002100739A4 (en) Neuramax

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase